Transform the production of oral solid dosage forms in the pharmaceutical industry with L.B. Bohle. L.B. Bohle supports companies with their machines and processes in adopting Continuous Manufacturing ...

Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...

Historically, pharmaceutical products have been produced in a traditional ‘batch’ system, in which every operation is executed separately using a defined quantity of materials. In batch manufacturing ...

Biologics manufacturers are under increasing pressure to reduce production costs. This is a key driver for moving to continuous processing, which maximizes productivity while minimizing footprint.

A photo of technicians working in front of a process train. Novartis's continuous manufacturing center in Basel, Switzerland, replicates an end-to-end manufacturing process developed at the ...

Using continuous processing instead of batch-based processing provides therapeutic manufacturers with a number of advantages. For example, the continuous approach can ...

One of the first digital manufacturing facilities in the world to use continuous, intensified biologics production technology Framingham, Massachusetts facility will manufacture biologics for the ...

SAN RAMON, Calif.--(BUSINESS WIRE)--GE Digital today announced that it scored in the top four across these critical capabilities: in-process quality management, data management/data collection, ...

NORFOLK, England--(BUSINESS WIRE)--μLOT® is an entirely new approach to manufacturing therapeutic peptides, which promises to completely replace traditional large-scale batch manufacturing. The µLOT® ...

The Industrial Internet of Things (IIoT) connects IoT with Industry. The IIoT allows companies to reap information from their machines and environments to create intelligent, self-learning machines.

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...